Silence Therapeutics

$23.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell SLN and other stocks, options, and ETFs commission-free!

About SLN

Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells.

CEO
Mark A. Rothera
Employees
—
Headquarters
London, Greater London
Founded
1994
Market Cap
722.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
625.90
High Today
—
Low Today
—
Open Price
—
Volume
0.00
52 Week High
$28.06
52 Week Low
$15.00

You May Also Like

ADUS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure